SCHEMBL26054552

SCHEMBL26054552

N#Cc1ccccc1-c1ccc(-c2nc(-c3ccc(-n4c5ccc(-c6ccccc6)cc5c5cc(-c6ccccc6)ccc54)cc3-c3ccccc3C#N)nc(-c3ccc(-n4c5ccc(-c6ccccc6)cc5c5cc(-c6ccccc6)ccc54)cc3-c3ccccc3C#N)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.41
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ESR2 Q92731 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
TRPA1 O75762 1/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
HSD17B10 Q99714 2/20 0.34
CLK4 Q9HAZ1 1/20 0.34
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26057457 0.97 NR3C1 (0.41) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL27016138 0.95 ALDH1A1 (0.38) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL26054735 0.95 NR3C1 (0.40) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL26054468 0.94 NR3C1 (0.37) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL26054626 0.94 NR3C1 (0.41) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL26054325 0.93 NR3C1 (0.39) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL27016233 0.93 ALDH1A1 (0.39) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL21364822 0.92 NR3C1 (0.40) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL27016137 0.92 NR3C1 (0.36) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL26054628 0.92 NR3C1 (0.37) NR3C1ALDH1A1HPGDMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES TYR, WIZ, NR2E3 NR3C1 1315/4885ALDH1A1 502/4885HPGD 2754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.